Identification of tumor malignancy is crucial to the clinical therapy of cancer. Presently, a biopsy is the gold standard for determining if a tumor is malignant in the majority of instances.
Nanotechnology Now - Press Release: An artificial intelligence probe help see tumor malignancy nanotech-now.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nanotech-now.com Daily Mail and Mail on Sunday newspapers.
Tumor malignancy identification plays an essential role in clinical management of cancer. Currently, biopsy is the gold standard for malignancy identification in most tumor cases, it is, however, invasive that can cause great discomfort to patients, and potentially increase the risk of distant metastases due to the complex sampling process.